Related references
Note: Only part of the references are listed.Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
Susan Prockop et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: A multicenter analysis
Shawn C. West et al.
CLINICAL TRANSPLANTATION (2019)
Post-transplant lymphoproliferative disease of the larynx
Nathan D. Vandjelovic et al.
JOURNAL OF SURGICAL CASE REPORTS (2019)
Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children
Fang Kuan Chiou et al.
PEDIATRIC TRANSPLANTATION (2018)
Outcome of shared care for pediatric cardiac transplantation between two nations with different health care systems
Jacob Simmonds et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
A 16-Year Multi-Institutional Study of the Role of Age and EBV Status on PTLD Incidence Among Pediatric Heart Transplant Recipients
R. Chinnock et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study
SA Webber et al.
LANCET (2006)
Share Paper
